Global Pediatric Vaccine Market
Pharmaceuticals

Comprehensive Forecast: Pediatric Vaccine Market Share, Growth, and Opportunities Through 2029

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Pediatric Vaccine Market Expected to Be in 2029?

The growth in the size of the pediatric vaccine market has been vigorous in the past few years. The market will expand from $44.2 billion in 2024 to $46.95 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. The surge in growth during the historic period can be ascribed to the rising occurrence of chronic diseases, the implementation of immunization policies to eliminate endemic diseases, and increased financing for vaccine research.

There is an anticipation of robust growth in the pediatric vaccine market size over the coming years. With a compound annual growth rate (CAGR) of 7.4%, it is expected to surge to “$62.48 billion by 2029.” This projected growth during the forecast period is largely due to the rising instances of invasive cervical cancer, a solid late-stage pipeline and new drug approvals, and the increasing prevalence of infectious diseases. Some major trends for this forecast period comprise the development of combination vaccines to fulfill market needs, investment consideration in Research and Development activities for creating potent vaccines, a concentration on creating live attenuated vaccines, use of innovative immune engineering and advanced delivery systems, and the application of artificial intelligence (AI) in vaccine creation to streamline the manufacturing process.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

What Are The Contributors To Demand In The Pediatric Vaccine Market?

The pediatric vaccines market is set to expand due to the increasing occurrence of chronic illnesses such as tuberculosis, diphtheria, and pneumonia in children aged 15 years and younger. Infectious diseases pose a greater threat of severe consequences and complications in children and teenagers who suffer from chronic conditions. As per the Australian Bureau of Statistics, a self-sufficient statutory agency in Australia responsible for collecting and assessing data, making factual suggestions, roughly 46.6% (equating to 11.6 million) of the total population had at least one chronic condition as of March 2022. The growing incidence of chronic illnesses in children enhances the necessity for protection from these diseases through immunization, thereby propelling the steady growth of the pediatric vaccine market.

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

Which Trends Are Redefining The Future Landscape Of The Pediatric Vaccine Industry?

There’s a consistent rise in the need for new and improved vaccines to safeguard against both communicable and challenging diseases like tuberculosis, HIV/AIDS, and chronic illnesses such as cancer and neurodegenerative conditions. The quest for innovation is evident in the advancements in the development of vaccines, which now include strategies like immunogenic structural design, gene-based vaccine platforms, and potent adjuvant recombinant antigen formulations. Recognizing this need to feed the rising demand, manufacturers and developers of pediatric vaccines are persistently striving for innovative design and production technologies. As an example of these advancements, Pfizer Inc., a pharmaceutical manufacturer based in the U.S., managed to secure the U.S. FDA’s approval for REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine suitable for infants and young children, in April 2023.

Who Are The Top-Ranked Companies In The Pediatric Vaccine Market Today?

Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos–Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

How Is Pediatric Vaccine Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2824&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model